[ad_1] T Afenoquine, developed by the British pharmaceutical company GSK and Medicines for Malaria Venture, is a single-dose treatment. Dr. Pauline Williams, head of global health research and development at GSK, said …
Read More »[ad_1] T Afenoquine, developed by the British pharmaceutical company GSK and Medicines for Malaria Venture, is a single-dose treatment. Dr. Pauline Williams, head of global health research and development at GSK, said …
Read More »